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Background: Systemic lupus erythematosus (SLE) is a chronic systemic inflammatory auto-
immune disease, the etiology of which remains only partially characterized. Strong evidence 
implicates chronic infections in the development and chronicity of autoimmune conditions. 
Recently, an association has been demonstrated between periodontitis and rheumatoid 
arthritis. Such observations have led to the investigation of the possible role of periodontitis 
and oral dysbiosis in other systemic inflammatory conditions, including SLE. The aim of this 
study was to examine whether there is an association between SLE and periodontitis.
Methods: MEDLINE via OVID, EMBASE via OVID, and PsycINFO via OVID databases 
were searched to identify eligible studies, screened by two independent authors and 
verified by a third. Studies comparing presence of periodontitis in SLE cases to controls 
without SLE were included. Data were extracted using a predefined table and papers 
were appraised using Down’s and Black tool. Mantel–Haenszel meta-analysis was per-
formed using RevMan.
results: Eight case–control studies were included, with 487 SLE cases and a total of 
1,383 participants. On meta-analysis of four studies, risk of periodontitis in SLE cases 
compared to controls was significantly greater with a risk ratio of 1.76 (95% CI 1.29–2.41, 
p = 0.0004). No statistical difference was found in individual measures of periodontitis, 
such as probing depth or clinical attachment loss, between SLE cases and controls.
conclusion: Our study found a statistically significant increased risk of periodontitis in 
patients with SLE compared to controls. This finding suggests a possible association 
between these two conditions. Larger longitudinal studies are needed to confirm this 
possible association.
Keywords: systemic lupus erythematosus, autoimmune and inflammatory diseases, microorganisms, 
periodontitis, periodontal disease, meta-analysis
inTrODUcTiOn
Systemic lupus erythematosus (SLE) is a systemic, chronic inflammatory condition with diverse 
clinical manifestations, primarily affecting the joints, internal organs, and the skin (1).
The etiology of SLE is incompletely understood, but it is thought to occur in genetically primed 
individuals in whom the inflammatory response is triggered by an environmental stimulus. 
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Immunosuppressant medications are the mainstay of treatment, 
but these are limited both in efficacy and by multiple side effects 
which lead to significant morbidity and mortality. Oral manifes-
tations of SLE are common and typically take the form of painless 
oral ulcers that are frequently present during disease flares and 
are included in current SLE classification criteria (2).
Periodontitis is an infectious-inflammatory condition, affect-
ing the periodontal ligament and alveolar bone (3). Most cases 
are due to the chronic accumulation of oral plaque which initiates 
inflammation, further bacterial colonization and tissue destruc-
tion. Gingivitis usually occurs first and can be reversed with oral 
hygiene methods. However, once the inflammation extends past 
the gums to the deeper tissues, the loss of periodontal attachment 
and bone causes progressive loosening of teeth, eventually leading 
to their loss (4). The “red complex” organisms, Porphyromonas 
gingivalis, Tannerella forsythia, and Treponema denticola, have a 
key role in the development of periodontitis (5, 6).
There is strong evidence that periodontitis, and specifically oral 
dysbiosis is associated with autoimmune inflammatory disease, 
principally rheumatoid arthritis (RA). A recent meta-analysis 
including 153,492 participants showed a significant association 
between periodontitis and rheumatoid arthritis (7). Two specific 
bacteria have been implicated in triggering the underlying 
inflammatory process, P. gingivalis (8, 9) and Aggregatibacter 
actinomycetemcomitans (10). Clinical trials are underway to 
investigate the effect of non-surgical treatment of periodontitis, 
such as oral hygiene and mechanical removal of plaque in RA.
There is increasing interest regarding the possible role of oral 
dysbiosis in the etiology of other autoimmune inflammatory con-
ditions, including SLE. Further understanding of any potential 
association between periodontitis and SLE would expand current 
knowledge of the etiology of SLE and may lead to novel manage-
ment strategies.
In this review, we hypothesized that there may be an associa-
tion between SLE and periodontitis. To evaluate this hypothesis, 
we conducted a systematic review and meta-analysis of relevant 
publications.
MaTerials anD MeThODs
The protocol for the review was registered with PROSPERO 
(Registration number: CRD42016053490) an international register 
of systematic reviews (http://www.crd.york.ac.uk/PROSPERO/). 
We used the Preferred Reporting Items for Systematic Reviews and 
Meta-Analyses (PRISMA) 2009 checklist to report the review (11).
eligibility criteria for Population
Participants in the studies needed to have a diagnosis of SLE based 
on internationally recognized criteria, ACR 1982/1997 revised 
classification criteria (12) or clinical diagnosis by a rheumatolo-
gist. Studies which included participants of all ages, gender, and 
disease severity were eligible.
eligibility criteria for study
To be included, studies needed to be observational studies of 
cross-sectional, case–control, or cohort design. Journal articles 
and conference proceedings were included. Review articles, 
case reports, animal model studies, and those with unavailable 
abstracts were excluded. Non-English language papers were 
excluded. There were no restrictions on date of publication or 
publication status.
eligibility criteria for Outcome Measure
To be included, prevalence of periodontitis using standardized 
measures needed to be reported in both SLE population and 
non-SLE population.
search strategy
MEDLINE via OVID, EMBASE via OVID, and PsycINFO via 
OVID databases were searched using the following terms: sys-
temic lupus erythematosus, SLE, lupus erythematosus, systemic 
or lupus nephritis, lupus vasculitis and Periodont*, gum disease, 
gingivitis, tooth decay, oral health, dental health, oral plaque 
index (PI), probing pocket depth, bleeding on probing (BOP), 
and clinical attachment loss (CAL). In addition, Google Scholar 
was searched using the following term “Periodontitis and sys-
temic lupus erythematosus.” The searches were re-run just before 
the final analyses on the 03/08/2017.
study selection
The Titles and/or abstracts were screened by two independent 
authors (Zoe Rutter-locher and Toby O. Smith) to identify poten-
tial eligible studies. Final selection of studies was performed by 
two independent authors (Zoe Rutter-locher and Toby O. Smith) 
and verified by a third author (Nidhi Sofat) by reviewing the full 
text based on inclusion criteria above. Any disagreements were 
resolved by discussion.
Data extraction
A standardized, pre-piloted form was used to extract data 
from the included studies. Extracted information included: 
(1) study design including, publication journal and date, inclu-
sion and exclusion criteria, diagnostic criteria of SLE, definition 
of periodontitis, (2) study participant demographics including % 
females, mean age, years of SLE disease, therapies, measure of 
severity of SLE, and (3) periodontal measures including preva-
lence of periodontitis, oral plaque index (PI), probing depth (PD), 
clinical attachment loss (CAL), and bleeding on probing (BOP). 
Two authors (Zoe Rutter-locher and Toby O. Smith) extracted the 
data independently, discrepancies were identified and resolved 
through discussion (with a third author, Nidhi Sofat, where 
necessary). Authors were contacted by email to obtain missing 
information and included when received.
Quality assessment
Risk of bias and quality assessment was reviewed using Downs 
and Black tool for non-randomized control trials (13). This 
27-point tool assesses studies on five key sections: (1) study 
quality (10 points), (2) external validity (3 points), (3) study bias 
(7 points), (4) confounding and selection bias (6 points), and 
(5) Power of the study (1 point). Disagreements between the 
review authors over the risk of bias in particular studies were 
resolved by discussion, with involvement of a third review author 
where necessary.
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Data analysis
As there was homogeneity in participants, study design and 
outcome measure on visual assessment of the data extraction 
table, a meta-analysis was performed. Primary outcome was to 
calculate relative risk of periodontitis in participants with SLE 
compared to participants without SLE. Secondary outcomes were 
to calculate relative risk or mean difference for measures of peri-
odontal disease. These measures of periodontal disease included 
PD, oral PI, BOP, bleeding gingival index, and CAL.
Median and interquartile range were converted to mean (SD) 
to allow comparison of studies, under the assumption of normal 
distribution. A fixed effect meta-analysis was performed when 
the inconsistency value (I-squared) was ≤50% and Chi-squared 
equates p = 0.10 and a random-effect meta-analysis when I-squared 
was >50% and Chi-squared equates to p < 0.10. Risk ratio with 
95% confidence intervals was calculated for the prevalence rates of 
periodontitis and the mean difference was calculated for continu-
ous variables. Risk of bias was identified in Down’s and Black tool. 
Publication bias was not performed as it is convention to only pre-
sent a funnel plot for 10 or more data points in a meta-analysis (14).
All analysis and forest plots were performed on RevMan 
Version 5.3 (Copenhagen: The Nordic Cochrane Centre, The 
Cochrane Collaboration, 2014).
resUlTs
search results
As shown in Figure 1, a total of 485 studies were identified using 
the search strategy. Of these, 454 were excluded as they were 
duplicates, non-English articles, review articles, or non-relevant. 
The 31 remaining full length articles were screened and eight 
were deemed appropriate to be included in the qualitative and 
quantitative analysis.
study Design
The study characteristics are shown in Table 1 and Table S1 in 
Supplementary Material. All studies included in the meta-analysis 
were case-control in design. Seven were published in peer review 
journals and one was taken from conference proceedings (15). 
Most studies (six of seven) were published since 2015. The remain-
ing articles were published between 1993 and 2007. Three studies 
were based in Europe (two in the UK and one in Germany), two 
in Brazil, one in Saudi Arabia, one in Taiwan, and one in China.
The total number of study participants was 1,383 which 
included 487 cases of SLE. All studies defined cases as fulfilling 
the ACR 1982/1997 revised classification criteria for diagnosis 
of SLE (12). Cases were recruited mainly from Rheumatology 
clinics, with the exception of Meyer et  al. who recruited from 
the “Department of Internal Medicine” (19). All studies defined 
controls as either “Healthy” or “Individuals without a history of 
rheumatic conditions or autoimmune disease.” Controls were 
recruited from a variety of sources including dental clinics, staff 
at the medical school and epidemiological survey. Most studies 
included exclusion criteria in order to reduce the effect of con-
founders such as age, smoking, recent antibiotics usage, but this 
varied between studies.
Quality assessment
Quality assessment was hindered by the limited information 
available for some studies, especially those that came from con-
ference proceedings. As shown in Table  2, studies included in 
this meta-analysis had clear hypothesis, outcome measures and 
aims (N = 8, 100%). The participants were representative of the 
population (N = 7, 88%) and the outcome measures were reliable 
and clearly reported (N =  8, 100%) with estimates of random 
variability (N = 7, 88%). Particular limitations were that assessors 
were not blinded (N = 1, 13%) and sufficiently powered cohort 
size was present in only half of studies (N = 4, 50%).
study Participant Demographics
Table 3 shows the demographic of the cohorts. A total of 1,383 
participants were included in the meta-analysis, with 487 par-
ticipants with SLE and 896 participants without SLE. Mean age of 
participants with SLE was 41.3 years and controls was 42.8 years, 
excluding juvenile SLE. All studies had a predominance of females. 
Mean duration of disease was, as expected, lowest in study by 
Fernandes et al. looking at juvenile SLE (18). Excluding this study, 
mean disease duration ranged from 4.5 to 11 years. Use of immu-
nosuppressant’s varied from 36 to 100%. There was also variability 
in what medications were included under the term “immunosup-
pression.” There was insufficient detailed data in order to control 
for immunosuppressant use in meta-analysis. Importantly, smok-
ing status, a known risk factor for periodontitis, was the same in 
cases and controls in those studies with available data.
Meta-analysis: sle and Periodontitis 
Prevalence
As shown in Table  4, all studies used similar measures of 
periodontitis. Four of the seven studies, which included 1,064 
participants, defined periodontitis (15, 17, 21–23). Three studies 
(15, 17, 22) differentiated between mild and severe periodontitis.
The prevalence rates of periodontitis were similar in these 
four studies. The exceptions were the lower prevalence rate of 
periodontitis in the controls of the study by Wang et  al. and 
Zhang et al. (21, 22). On meta-analysis, risk of periodontitis in 
SLE patients compared to controls was significantly greater with 
a risk ratio of 1.76 (95% CI 1.29–2.41, p =  0.0004, Figure  2). 
Furthermore, this greater risk ratio remained significant when 
the study published as a conference proceeding was excluded 
from the meta-analysis (RR 2.05 95% CI 1.15–3.66, p = 0.02) and 
when the study by Wang et al. was excluded from meta-analysis 
(RR 1.50 95% CI 1.28–1.75, p < 0.00001). Interestingly two stud-
ies which differentiated between mild and severe periodontitis 
found no difference in the prevalence of severe periodontitis 
between cases and controls, whereas one did (22).
Meta-analysis: sle and Measures of 
Periodontal Disease
All studies provided data on measures of periodontal disease. 
Six of the eight studies reported oral PI (16, 18–20, 22, 23). Six 
of the studies reported on presence of gingivitis (16–20, 22, 23), 
with five reporting BOP and two Loe and Silness gingival index 
(20, 22). Six studies provided data on PD (15–17, 20–23) and four 
FigUre 1 | PRISMA flow diagram showing results of search strategy.
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on CAL (16, 17, 21–23) which are the gold standard measures of 
periodontitis. Four studies reported on residual teeth (16, 19–21), 
and two reported the WHO DMFT index (decayed-missing-filled 
teeth index) (18, 19). Meyer et al. and Zhang et al. were the only 
studies to use radiographs to measure bone loss, an accurate 
measure of periodontitis (19, 22).
Number of residual teeth was very similar in all studies. 
Overall, the mean residual teeth count was 23.68 for SLE and 
23.65 for controls. On meta-analysis there was no significant 
difference in mean of PI (0.03, 95% CI −0.09–0.16, p =  0.62, 
Table 5, Figure S1 in Supplementary Material) or BOP (1.60, 95% 
CI −0.72–3.92, p =  0.18, Table 5, Figure S2 in Supplementary 
Material).
We also performed meta-analysis on the gold standard measures 
of periodontitis. Risk of PD ≥ 5 mm was greater in SLE patients 
compared to controls but this was not statistically significant with 
risk ratio of 1.34 (95% CI 0.99–1.82, p = 0.06, Table 5, Figure S3 in 
Supplementary Material). Risk of CAL ≥ 2 and difference in means 
for PD and CAL were not statistically different between cases 
and controls; Risk of CAL ≥ 2 risk ratio 1.09 (95% CI 0.99–1.21, 
p = 0.08, Table 5, Figure S4 in Supplementary Material), PD differ-
ence in means 0.08 (95% CI −0.27–0.43, p = 0.66, Table 5, Figure 
S5 in Supplementary Material), CAL difference in means 0.41 
(95% CI −0.12–0.95, p = 0.13, Table 5, Figure S6 in Supplementary 
Material). Excluding the study in Juvenile SLE by Fernandes et al. 
did not make a significant difference to any outcome.
TaBle 2 | Down and Black’s appraisal.
1 2 3 4 5 6 7 8
Hypotheses/aims/objectives clearly described ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓
Main outcome measures clearly described ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓
Characteristics of patients/subjects clearly described 𝛘 ✓ NS ✓ 𝛘 𝛘 ✓ ✓
Interventions of interest clearly described ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓
Distribution of principal confounders in each group clearly described ✓ ✓ NS ✓ 𝛘 𝛘 ✓ ✓
Main findings clearly described ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓
Estimates of random variability in the data provided ✓ ✓ ✓ ✓ ✓ ✓ 𝛘 ✓
Important adverse events reported N/A N/A N/A N/A N/A N/A N/A N/A
Characteristics of patients lost to follow-up described N/A N/A N/A N/A N/A N/A N/A N/A
Actual probability values reported ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓
Participants approached representative of entire population ✓ ✓ ✓ 𝛘 ✓ ✓ ✓ ✓
Participants recruited representative of entire population ✓ ✓ ✓ 𝛘 ✓ ✓ ✓ ✓
Staff, places, and facilities were patients treated representative of majority of population ✓ ✓ ✓ 𝛘 ✓ ✓ ✓ ✓
Blinding of study subjects N/A N/A N/A N/A N/A N/A N/A N/A
Blinding of assessors 𝛘 𝛘 NS 𝛘 𝛘 𝛘 𝛘 ✓
Data based on data-dredging clearly stated N/A N/A N/A N/A N/A N/A N/A N/A
Time period between the intervention and outcome the same for cases and controls N/A N/A N/A N/A N/A N/A N/A N/A
Appropriate statistical tests used ✓ ✓ NS ✓ ✓ ✓ ✓ ✓
Compliance to intervention reliable N/A N/A N/A N/A N/A N/A N/A N/A
Main outcome measure reliable and valid ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓
Intervention groups or case–controls recruited from same population ✓ ✓ ✓ ✓ NS 𝛘 NS ✓
Intervention groups or case–controls recruited at the same time ✓ ✓ NS ✓ ✓ ✓ ✓ ✓
Study subjects randomized to the interventions N/A N/A N/A N/A N/A N/A N/A N/A
Was concealed randomization to allocation undertaken N/A N/A N/A N/A N/A N/A N/A N/A
Adequate adjustment made in the analysis of confounders ✓ ✓ ✓ ✓ 𝛘 ✓ ✓ ✓
Patient losses accounted for N/A N/A N/A N/A N/A N/A N/A N/A
Sufficiently powered cohort size 𝛘 ✓ ✓ 𝛘 𝛘 𝛘 ✓ ✓
S, not stated; N/A, not applicable.
1, Al-Mutari et al. (16); 2, Calderaro et al. (17); 3, de Pablo et al. (15); 4, Fernandes et al. (18); 5, Meyer et al. (19); 6, Mutlu et al. (20); 7, Wang et al. (21); 8, Zhang et al (22).
TaBle 1 | Study Characteristics.
reference country Time period systemic lupus 
erythematosus 
(sle) cases
control inclusion criteria 
cases
exclusion criteria cases
Al-Mutairi et al. (16) Saudi Arabia 2012–2014 25 50 Diagnosis SLE, 
female, >20 years 
old
Smoking, pregnancy, diabetes mellitus, history of periodontal 
treatment in the preceding 6 months, antibiotic prophylaxis
Calderaro et al. (17) Brazil 2013–2014 75 75 Diagnosis SLE, 
>18 years old, >8 
teeth
SLE overlap diseases, treatment of periodontitis in the preceding 
6 months, antibiotics in the preceding 3 months, antibiotic 
prophylaxis, end-stage renal failure, pregnancy or lactation, 
neoplasia in preceding 5 years, acute or chronic infections
de Pablo et al. (15) UK Not stated 105 484 Diagnosis SLE Unknown
Fernandes et al. (18) Brazil 2004–2005 48 48 Diagnosis juvenile 
SLE
Current periodontal treatment
Meyer et al. (19) Germany 1995–1996 46 50 Diagnosis SLE Current antibiotic or antiviral treatment
Mutlu et al. (20) UK Not stated 27 25 Diagnosis SLE Pregnancy, antibiotics in the preceding 6 months, history of 
periodontal disease
Wang et al. (21) Taiwan 2012–2013 53 56 Diagnosis SLE Smoking, antibiotics in the preceding 3 months, periodontal 
treatment in the preceding 3 months
Zhang et al. (22) China 2015–2016 108 108 Diagnosis of SLE Hearing and cognitive impairment, diabetes, renal failure, 
pregnancy, and lactation, cancer, history of periodontal 
treatment preceding 3 months, antibiotics preceding 3 months, 
number teeth <4
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DiscUssiOn
Our report is the first systematic review to examine the associa-
tion between periodontitis and SLE. On meta-analysis we found 
a statistically significant overall increased risk of periodontitis in 
patients with SLE compared to controls, suggesting an association 
between these two conditions. However, there was no statistical 
difference in individual measures of periodontitis, such as PD or 
CAL, between SLE cases and controls.
We found no significant difference in oral PI or BOP between 
SLE cases and controls. Plaque induced periodontitis is the most 
common form of periodontitis, and so a high oral PI would suggest 
FigUre 2 | Forest-plot representing risk ratio of periodontitis between cases with systemic lupus erythematosus (SLE) and healthy controls.
TaBle 4 | Definition of periodontitis and measures of periodontitis.
reference Definition of periodontitis Measure oral plaque 
build up
Measure gingivitis Measure periodontitis
Al-Mutairi et al. (16) None PI BOP RT, PD, CAL
Calderaro et al. (17) ≥2 sites PD ≥ 4 mm and ≥2 sites CAL ≥ 3 mm or 1 site 
PD ≥ 5 mm
PI BOP PD, CAL
de Pablo et al. (15) ≥1 sites PD ≥ 5 mm None None PD
Fernandes et al. (18) None PI BOP DMFT
Meyer et al. (19) None PI BOP Bone loss, RT, DMFT
Mutlu et al. (20) None Pl Loe and Silness GI RT, PD
Wang et al. (21) ≥20% of tooth sites with PD ≥ 4 mm or CAL ≥ 4 mm None None TT, PD, CAL
Zhang et al. (22) CAL > 3 combined with panoramic radiographs PI BOP, GI Bone loss, PD, CAL
PI, oral plaque index; BOP, bleeding on probing; GI, gingival index; MT, residual teeth; PD, probing depth; CAP, clinical attachment loss; DMFT, decayed-missing-filled index; CAL, 
clinical attachment loss.
TaBle 3 | Demographic of cohorts.
reference Mean age sle/
controls
% Females, sle/
controls
Years of 
sle disease 
(mean)
Use prednisolone 
(% sle)
Use of immunosuppressant 
(% sle)
smoking status 
sle/controls
Al-Mutairi et al. (16) 33/37 100/100 6.5 100 36 0/0
Calderaro et al. (17) 38/41 91/77 11 83 79 11/11
de Pablo et al. (15) 46/49 92/56 DM DM DM DM
Fernandes et al. (18) 14/13 85/67 3.1 98 48 0/0
Meyer et al. (19) 40/46 DM 4.5 DM DM DM
Mutlu et al. (20) 48/44 96/92 DM 81a 81 a DM
Wang et al. (21) 47/44 100/100 DM DM 100 0/0
Zhang et al. (22) 37/39 100/100 7.5 67 41 DM
DM, data missing.
aUse prednisolone or immunosuppression.
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a greater risk of developing periodontitis. BOP is a measure of 
gingivitis, the reversible gingival inflammation which precedes 
periodontitis. Therefore, although these measures do highlight 
potential risk of periodontitis, the absence of a significant differ-
ence between cases and controls does not preclude an association 
between SLE and periodontitis.
There was also no difference in means of PD. PD calculates 
the depth of periodontal pockets and is a measure of current 
periodontal disease. The British Society of Periodontology delin-
eates a healthy sulcus as <3.5 mm and a periodontal pocket as 
≥3.5 mm (24). We propose that calculating differences in mean 
PD < 3.5 mm is, therefore, not clinically significant and risk ratio 
of PD above a certain level is more appropriate. In this case, the 
finding that PD ≥ 5 mm was higher in SLE potentially supports 
the evidence that periodontitis is associated with SLE. However, 
as this was not significant further studies with larger sample size 
will be needed to elucidate this further.
Clinical attachment loss is the other gold standard measure-
ment for periodontitis (25) and is representative of cumulative 
destruction. Although CAL ≥ 2 mm and mean difference in CAL 
was higher in SLE compared to controls, this not significantly 
different. Again, further studies are needed to investigate this 
relationship.
The finding that periodontitis is associated with SLE is in 
agreement with other studies examining this relationship. Case 
studies since the 1980s have suggested a link between SLE and 
gum disease. Rhodus and Johnson found 93.8% of SLE patients 
had periodontitis (26), while a Japanese study reported a 
TaBle 5 | Results from meta-analysis.
Outcome relative risk  
(95% ci)
p value N statistical 
heterogeneity  
(I2; chi2)
Periodontitis 1.76 (1.29–2.41) <0.01 1,064 86%; 0.0001
Pla 0.03 (−0.09–0.16) 0.62 685 94%; <0.0001
Bleeding on 
probinga
1.60 (−0.72–3.92) 0.18 633 41%; 0.15
Probing depth 
(PD) ≥ 5 mm
1.34 (0.99–1.82) 0.06 923 68%; 0.03
Clinical 
attachment loss 
(CAL) ≥ 2 mm
1.09 (0.99–1.21) 0.08 334 42%; 0.18
PD (mm)a 0.08 (−0.27–0.43) 0.66 493 99%; <0.0001
CAL (mm)a 0.41 (−0.12–0.95) 0.13 441 87%; 0.0005
aMean difference analysis.
CI, confidence intervals.
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prevalence of periodontitis of 70% in SLE compared to 30% in 
the general population (27). Higher disease activity, measured 
by SLE Disease Activity Index (SLEDAI) (28), predicts worse 
periodontal disease (24, 29) and non-surgical treatment of peri-
odontitis improves SLEDAI scores at 3 months (30). These find-
ings suggest that oral dysbiosis may contribute to maintenance 
of the inflammatory process in SLE. Recently, differences in the 
composition of the oral microbiota, independent of periodontal 
status, have been elucidated using 16s ribosome sequencing in 
52 cases of SLE (23). Interestingly, the periodontal pathogen 
Aggregatibacter actinomycetemcomitans, which has been identi-
fied as a potential trigger in RA (10), has also been implicated 
in SLE (31).
Systemic lupus erythematosus is thought to occur when an 
environmental stimulus triggers inflammation in a genetically 
primed individual. Initial studies have highlighted possible 
mechanisms to explain the potential association between peri-
odontitis and SLE. Genetic variants in the Fcy receptor have been 
implicated in susceptibility to both SLE and periodontitis in a 
small Japanese study (32). Periodontitis and SLE are both inflam-
matory conditions, and share similar inflammatory profiles 
(33, 34). Specifically, a possible role for TLR-4 has been 
implicated. These molecules are activated by specific pathogen-
associated molecular patterns produced by bacteria and 
stimulation of TLR-4 leads to autoimmune lupus in mice (35). 
However, it must be emphasized that these studies are small 
and much more work is needed to elucidate if there is any 
biological plausibility.
study limitations
A significant limitation to our meta-analysis is the lack of clear 
and recognized criteria to define periodontitis. Although all defi-
nitions of periodontitis used PD and CAL, they did vary in their 
thresholds, limiting the ability to directly compare outcomes. 
However, a minimum diagnostic threshold of CAL  ≥  2  mm 
and PD ≥  3  mm has been suggested (25) and all studies used 
thresholds which surpassed these cutoffs.
Another significant limitation is the paucity of data available. 
Only eight studies could be included in the meta-analysis. The 
overall periodontitis risk ratio included only four studies, and one 
of these was from conference proceedings. Meta-analysis involv-
ing greater number of studies analyzing individual measures 
of periodontitis were not significant. This may suggest that the 
significant risk ratio in overall periodontitis cannot be extrapo-
lated into larger study populations. However, previous similar 
meta-analysis in other conditions, which have included larger 
numbers of studies, have also found that overall periodontitis risk 
is significant, while individual markers are not (7).
There are only a small number of studies to date investigating 
this association and so we were unable to test for publication bias. 
We included data from conference proceedings try to mitigate 
this but it will be important in the future to ascertain the risk of 
small sample size publication bias.
There are a number of factors such as smoking, educational 
level, and immunosuppressant medications which increased risk 
of both SLE and periodontitis (1). Variation in the prevalence of 
these factors between cases and controls could, in part, be respon-
sible for the differences seen. These factors were partly controlled 
for by the use of exclusion criteria in some studies. However, there 
was limited detailed information regarding smoking status and 
immunosuppressant use in most studies, and information that 
was available showed variations in immunosuppressant use from 
36 to 100%.
Finally, all studies included were cross-sectional in nature 
and investigated an association at a given time point. We are, 
therefore, unable to make any conclusions regarding causality 
from this study. Further longitudinal studies are needed to deline-
ate a temporal association and causality of periodontitis in the 
development of SLE.
cOnclUsiOn
The results of this meta-analysis show a significant association 
between SLE and periodontitis. However, the meta-analysis was 
hampered by paucity of data and significant limitations. Therefore, 
these findings can only suggest a possible association and larger 
longitudinal studies are needed to confirm this association and 
investigate causality of periodontitis in SLE.
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